ArticleJournal of clinical medicine2023

Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.

Michail Vikelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.